JS

Jeffrey Stafford

Chief Executive Officer

858 Therapeutics

California


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
858 Therapeutics
Industry
research
Employees
25.0
Seniority
C suite
Total Funding
110000000.0
Latest Funding
Series B

Technologies

Gmail Google Apps Mobile Friendly Google Tag Manager Render Basis Remote Circle Micro AI

Keywords

biotechnology research small molecule drugs drug discovery biotechnology oncology therapeutics immunology parg inhibitors poly-adp-ribose polymerase rna modulation synthetic lethality clinical development solid tumors biotech hub translational research preclinical data fda-approved drugs drug candidates therapeutic targets tumor growth inhibition pharmacological inhibition drug licensing clinical trials molecular pharmacology biopharmaceuticals differentiated drug candidates biologics treatment resistance cancer stem cells indications pharmacodynamics drug development strategy pipeline progression drug discovery collaboration investor relations biotech investments leadership team scientific advisors clinical oncology partnership opportunities drug metabolism structure-based drug design target identification patient outcomes innovative therapeutics drug efficacy biomarker-driven therapy research partnerships leadership positions drug safety biotech careers health care health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans